SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 27 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,827,240 | $2,083,054 | 0.49% |
| Deuterium Capital Management, LLC | 22,000 | $25,080 | 0.02% |
| Duquesne Family Office | 100,000 | $114 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $128,706 | 0.00% |
| LEO BROKERAGE, LLC | 14,845 | $16,923 | 0.00% |
| UBS Group AG | 6,511 | $7,423 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 13,576 | $15,477 | 0.00% |
| FMR LLC | 8 | $9 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $13,190 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 90,774 | $103,482 | 0.00% |
| WELLS FARGO & COMPANY/MN | 132 | $150 | 0.00% |
| NORTHERN TRUST CORP | 26,049 | $29,696 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 98,006 | $111,726 | 0.00% |
| STATE STREET CORP | 25,774 | $29,382 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 54,210 | $61,799 | 0.00% |
| HARBOUR INVESTMENTS, INC. | 3 | $3 | 0.00% |
| MORGAN STANLEY | 219 | $250 | 0.00% |
| BlackRock Inc. | 36,667 | $41,801 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,900 | $28,386 | 0.00% |
External links
This page lists SENSEI BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view SENSEI BIOTHERAPEUTICS INC's shareholder history, click here.